In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis

As a consequence of emerging numbers of vulvovaginitis cases caused by azole-resistant and biofilm-forming Candida species, fast and efficient treatment of this infection has become challenging. The problem is further exacerbated by the severe side effects of azoles as long-term-use medications in t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Kovács, Renátó, Holzknecht, Jeanett, Hargitai, Zoltán, Papp, Csaba, Farkas, Attila, Borics, Attila, Tóth, Lilána, Váradi, Györgyi, Tóth, Gábor K., Kovács, Ilona, Dubrac, Sandrine, Majoros, László, Marx, Florentine, Galgóczy, László
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2019
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355578/
https://ncbi.nlm.nih.gov/pubmed/30478163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01777-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky